← Back to All Stocks

ImmunityBio, Inc. (IBRX) Analysis

Generated on: 2025-08-20 18:29:53 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.

Analysis Values

Current Price
$2.22
Predicted Price
$2.37
Expected Return
5.77%
Confidence Score
0.86
RSI (14)
39.34
MACD
-0.09
Volume
5,441,751
Float Shares
193,559,802
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
251

IBRX

ImmunityBio, Inc.
5.77%
Price: $2.22
Confidence: 0.86
News
Last updated: 2025-08-20 18:29:53

Technical Analysis

RSI: 39.34
MACD: -0.09
Technical Analysis Graph

Risk Analysis

Volatility
100.39%
Max Drawdown
-69.37%
Beta
1.0
Risk Score
87.9

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
ImmunityBio (IBRX) Reports 60% Revenue Growth as ANKTIVA Adoption Accelerates
Insider Monkey - 2025-08-17 21:58
We recently published 12 Best Healthcare Stocks to Buy Under $30. ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best healthcare stocks. ImmunityBio, Inc. (NASDAQ:IBRX) is among the best healthcare stocks. It is a clinical-stage biotech company developing advanced immunotherapies and vaccines targeting cancers and infectious diseases by activating immune cells such as natural killer and T […]

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.